In the Original Investigation titled “Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations,”[1] published on October 28, 2020, there were errors in the byline, affiliations, and Conflict of Interest Disclosures. Dr Conteduca’s and Dr Lavaud’s names appeared incorrectly in the byline. Dr Conteduca is not affiliated with the Department of Medical Oncology, Weill Cornell Medicine. Drs Mehra and Kuppen’s affiliation should have read Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Dr Conteduca’s conflict of interest disclosure was omitted. This article has been corrected.[1]
Authors: Sabine Schmid; Aurelius Omlin; Celestia Higano; Christopher Sweeney; Nieves Martinez Chanza; Niven Mehra; Malou C P Kuppen; Himisha Beltran; Vincenza Conteduca; Daniel Vargas Pivato de Almeida; Fernando Cotait Maluf; William K Oh; Che-Kai Tsao; Oliver Sartor; Elisa Ledet; Giuseppe Di Lorenzo; Steven M Yip; Kim N Chi; Diletta Bianchini; Ugo De Giorgi; Aaron R Hansen; Tomasz M Beer; Pernelle Lavaud; Rafael Morales-Barrera; Marcello Tucci; Elena Castro; Kostas Karalis; Andries M Bergman; Mo Linh Le; Ursina Zürrer-Härdi; Carmel Pezaro; Hiroyoshi Suzuki; Andrea Zivi; Dirk Klingbiel; Sämi Schär; Silke Gillessen Journal: JAMA Netw Open Date: 2020-10-01